Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

Sulfamethoxazole and Trimethoprim Tablet Production

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This subcontract involves the production of USP-grade Sulfamethoxazole and Trimethoprim tablets in 400 mg/80 mg dosages for prime contractors supporting Department of Defense medical supply contracts. The selected manufacturer is responsible for formulating active pharmaceutical ingredients into tablets that adhere to strict USP specifications for potency and purity, ensuring a minimum shelf life of 36 months. Finished products must be delivered in bulk bottles containing 500 tablets each. To qualify, the provider must operate an FDA-registered pharmaceutical manufacturing facility and maintain full compliance with current Good Manufacturing Practices. The project is managed under the Medical Supply Chain Pharm FSA and is associated with performance in Fort Bragg. Interested parties should note the response deadline of October 26, 2026.

General Info

FDA-registered manufacturer to produce USP-grade Sulfamethoxazole and Trimethoprim tablets by October 26, 2026.

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

FORT BRAGG, NC, 28310, USA

Set-Aside

NONE

Documents

This scope was carved out of SPE2DP-27-T-0136.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

SULFAMETHOXAZOLE AND T

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
ContactsNo contacts available
OfficeN/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Manufactures USP-grade Sulfamethoxazole and Trimethoprim tablets (400 mg/80 mg) for prime contractors on DLA medical supply contracts. Formulates active pharmaceutical ingredients into tablet form ensuring potency and purity meet USP specifications and a 36-month shelf life. Requires FDA-registered pharmaceutical manufacturing facility and cGMP compliance. Delivers bulk bottles of 500 tablets per bottle.

Similar Contracts

Same NAICS industry code

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS